FIRST TRACKS BIOTHERAPEUTICS, INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-08-12: Form 10-Q; Exhibit 10.10; Description Form of Indemnity Agreement..
- 2026-08-12: Form 10-Q; Exhibit 10.9; Description Wateridge Sublease Agreement.
- 2026-05-14: Form 10-Q; Exhibit 10.8; Description Amendment No. 1 to License Agreement, dated April 9, 2024, by and between the Registrant and Centessa Pharmaceuticals (UK) Limited..
- 2026-05-14: Form 10-Q; Exhibit 10.7; Description License Agreement, dated November 24, 2023, by and between the Registrant and Centessa Pharmaceuticals (UK) Limited.
| Filed | Form | Exhibit | Description |
|---|
| 2026-08-12 | 10-Q | 10.10 | Form of Indemnity Agreement. |
|---|
| 2026-08-12 | 10-Q | 10.9 | Wateridge Sublease Agreement |
|---|
| 2026-05-14 | 10-Q | 10.8 | Amendment No. 1 to License Agreement, dated April 9, 2024, by and between the Registrant and Centessa Pharmaceuticals (UK) Limited. |
|---|
| 2026-05-14 | 10-Q | 10.7 | License Agreement, dated November 24, 2023, by and between the Registrant and Centessa Pharmaceuticals (UK) Limited |
|---|
| 2026-05-14 | 10-Q | 10.6 | Employment Agreement, effective April 20, 2026, by and between the Registrant and Benjamin Stone |
|---|
| 2026-05-14 | 10-Q | 10.5 | Employment Agreement, effective April 20, 2026, by and between the Registrant and Ajim Tamboli |
|---|
| 2026-05-14 | 10-Q | 10.4 | Employment Agreement, effective April 20, 2026, by and between the Registrant and Paul Lizzul |
|---|
| 2026-05-14 | 10-Q | 10.3 | Employment Agreement, effective April 20, 2026, by and between the Registrant and Daniel Faga |
|---|
| 2026-04-20 | 8-K | 10.2 | Registration Rights Agreement, dated as of April 20, 2026, by and among the Company and the Investors party thereto.†+ |
|---|
| 2026-04-20 | 8-K | 10.1 | Transition Services Agreement, dated as of April 20, 2026, by and between AnaptysBio, Inc. and First Tracks Biotherapeutics, Inc.† |
|---|